Viva Biotech Holdings (HK:1873) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Viva Biotech Holdings reported its interim financial results for the six months ending June 30, 2024, revealing a net profit surge to RMB 144.2 million from RMB 13.7 million in the previous year. Despite a slight decrease in revenue and gross profit margin, the company’s adjusted non-IFRS net profit increased, indicating a stronger underlying business performance. These financial highlights demonstrate Viva Biotech’s growth and operational success, excluding certain non-recurring and non-cash items for a more accurate representation of the company’s earnings.
For further insights into HK:1873 stock, check out TipRanks’ Stock Analysis page.